Measuring decision quality: Psychometric evaluation of a new instrument for breast cancer chemotherapy

BMC Medical Informatics and Decision Making

Volumn 14, Issue 1, 2014, Pages

  Lee, Clara N ^a   Wetschler, Matthew H ^b   Chang, Yuchiao ^c   Belkora, Jeffrey K ^d   Moy, Beverly ^c   Partridge, Ann ^c   Sepucha, Karen R ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant therapy; Breast cancer; Chemotherapy; Decision; Decision quality; Quality of care; Regret; Shared decision making

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; DEVICES; FEMALE; HEALTH CARE QUALITY; HUMAN; MIDDLE AGED; PSYCHOMETRY; QUESTIONNAIRE; STANDARDS;

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; MIDDLE AGED; PSYCHOMETRICS; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES;

EID: 84908543322     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/1472-6947-14-73     Document Type: Article

References (35)

1. Breast cancer: clinical practice guidelines in oncology. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Keil K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC, J Natl Compr Canc Netw 2009 7 2 122 192 19200416
2. Breast cancer, version 3.2013: featured updates to the NCCN guidelines. Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R, J Natl Compr Canc Netw 2013 11 7 753 760 23847214
3. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP, JAMA 2006 295 14 1658 1667 10.1001/jama.295.14.1658 16609087
4. Effect of screening and adjuvant therapy on mortality from breast cancer. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer intervention and surveillance modeling network collaborators, N Engl J Med 2005 353 17 1784 1792 10.1056/NEJMoa050518 16251534
5. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K, Early Breast Cancer Trialists' Collaborative G, Lancet 2012 379 9814 432 444 22152853
6. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Whelan T, BMJ 2006 333 7565 417 10.1136/bmj.38926.629329.AE 16908462
7. Information needs and decisional preferences in women with breast cancer. Degner L, Kristijanson L, Bowman D, Sloan J, Carriere K, O'Neil J, Bilodeau B, Watson P, Mueller B, JAMA 1997 277 18 1485 1492 10.1001/jama.1997.03540420081039 9145723
8. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. Ravdin PM, Siminoff IA, Harvey JA, J Clin Oncol 1998 16 2 515 521 9469335
9. Does use of the adjuvant! model influence use of adjuvant therapy through better risk communication? Belkora JK, Hutton DW, Moore DH, Siminoff LA, J Natl Compr Canc Netw 2011 9 7 707 712 21715722
10. Are patients getting the "gist" in risk communication? Patient understanding of prognosis in breast cancer treatment. Hutton DW, Belkora JK, Shachter RD, Moore DH, J Cancer Educ 2009 24 3 194 199 10.1080/08858190902876452 19526406
11. Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis. Belkora JK, Rugo HS, Moore DH, Hutton DW, Chen DF, Esserman LJ, BMC Cancer 2009 9 127 10.1186/1471-2407-9-127 19400938
12. Risk communication with breast cancer patients: a cautionary note about printing adjuvant! Screenshots. Belkora JK, Rugo HS, Moore DH, Hutton D, Esserman LJ, Lancet Oncol 2008 In Press
13. Doctor-patient communication about breast cancer adjuvant therapy. Siminoff LA, Fetting JH, Abeloff MD, J Clin Oncol 1989 7 9 1192 1200 2671280
14. Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Bruera E, Willey JS, Palmer JL, Rosales M, Cancer 2002 94 7 2076 2080 10.1002/cncr.10393 11932912
15. Improving communication with cancer patients. Siminoff LA, Oncology 1992 6 10 83 87 discussion 87-89
16. Doctor-patient communication patterns in breast cancer adjuvant therapy discussions. Siminoff L, Ravdin P, Colabianchi N, Sturm C, Health Expect 2000 3 1 26 36 10.1046/j.1369-6513.2000.00074.x 11281909
17. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL, J Clin Oncol 2001 19 4 980 991 11181660
18. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? Simes RJ, Coates AS, J Natl Cancer Inst Monogr 2001 30 146 152 11773309
19. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Duric VM, Stockler MR, Heritier S, Boyle F, Beith J, Sullivan A, Wilcken N, Coates AS, Simes RJ, Ann Oncol 2005 16 11 1786 1794 10.1093/annonc/mdi370 16126738
20. Assessing patients' utilities: can the ends justify the means? Mulley AG, Med Care 1989 27 3 Suppl 269 S281 2646492
21. A perspective on the patient's role in treatment decisions. Sepucha K, Mulley A, Med Care Res Rev 2008 in press
22. Fowler F, Improving Survey Questions Thousand Paks, CA: Sage Publiations, Inc. 2002 38
23. Fowler F, Survey Research Methods Thousand Oaks, CA: Sage Publications, Inc 1993 1
24. DeVellis R, Scale Development Theory and Applications Thousand Oaks: Sage Publications 2 2003 26
25. Developing instruments to measure the quality of decisions: early results for a set of symptom-driven decisions. Sepucha KR, Levin CA, Uzogara EE, Barry MJ, O'Connor AM, Mulley AG, Patient Educ Couns 2008 73 3 504 510 10.1016/j.pec.2008.07.009 18718734
26. Development of instruments to measure the quality of breast cancer treatment decisions. Lee CN, Dominik R, Levin CA, Barry MJ, Cosenza C, O'Connor AM, Mulley AG, Sepucha K, Health Expect 2010 13 3 258 272 20550591
27. The role of perceived benefits and costs in patients' medical decisions. Singer E, Couper MP, Fagerlin A, Fowler FJ, Levin CA, Ubel PA, Van Hoewyk J, Zikmund-Fisher BJ, Health Expect 2014 17 1 4 14 10.1111/j.1369-7625.2011.00739.x 22070416
28. The DECISIONS study: a nationwide survey of United States adults regarding 9 common medical decisions. Zikmund-Fisher BJ, Couper MP, Singer E, Levin CA, Fowler FJ Jr, Ziniel S, Ubel PA, Fagerlin A, Med Decis Making 2010 30 5 Suppl 20S 34S 10.1177/0272989X09353792 20393104
29. Decision dissonance: evaluating an approach to measuring the quality of surgical decision making. Fowler FJ Jr, Gallagher PM, Drake KM, Sepucha KR, Jt Comm J Qual Patient Saf 2013 39 3 136 144 23516764
30. Medical oncologists' perceptions of financial incentives in cancer care. Malin JL, Weeks JC, Potosky AL, Hornbrook MC, Keating NL, J Clin Oncol 2013 31 5 530 535 10.1200/JCO.2012.43.6063 23269996
31. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. Whelan T, Sawka C, Levine M, Gafni A, Reyno L, Willan A, Julian J, Dent S, Abu-Zahra H, Chouinard E, Tozer R, Pritchard K, Bodendorfer I, J Natl Cancer Inst 2003 95 8 581 587 10.1093/jnci/95.8.581 12697850
32. Breast irradiation post lumpectomy: development and evaluation of a decision instrument. Whelan TJ, Levine MN, Gafni A, Lukka H, Mohide E, Patel M, Streiner D, J Clin Oncol 1995 13 847 853 7707110
33. Mastectomy or lumpectomy? Helping women make informed choices. Whelan T, Levine M, Gafni A, Sanders K, Willan A, Mirsky D, Schnider D, McCready D, Reid S, Kobylecky A, Reed K, J Clin Oncol 1999 17 6 1727 1735 10561209
34. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA, Beith J, Boyle F, Friedlander ML, Lancet Oncol 2005 6 8 581 588 10.1016/S1470-2045(05)70254-0 16054569
35. Decision making about surgery for early-stage breast cancer. Lee CN, Chang Y, Adimorah N, Belkora JK, Moy B, Partridge AH, Ollila DW, Sepucha KR, J Am Coll Surg 2012 214 1 1 10 10.1016/j.jamcollsurg.2011.09.017 22056355